Recent advances in molecular biology have made the prospect of gene therapy
for prostate cancer a reality. A wide variety of genetic strategies, vecto
r designs, and delivery modalities are currently in use. This article exami
nes the state of the art prostate cancer gene therapy and details the vario
us options available to clinicians.